FDCDDQ
AXSM icon

Federation des caisses Desjardins du Quebec’s Axsome Therapeutics AXSM Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$677K Buy
2,764
+441
+19% +$95.6K ﹤0.01% 1248
2026
Q1 		$393K Buy
+2,323
New +$401K ﹤0.01% 1354
2021
Q4 		– Sell
-200
Closed -$6.59K – 2525
2021
Q3 		$6.59K Buy
+200
New +$7.79K ﹤0.01% 2166

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's AXSM Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Axsome Therapeutics (AXSM) stake by 19% in Q2 2026, buying an estimated $95.6K and bringing the position to 2,764 shares worth $677K. The position accounts for ﹤0.01% of the portfolio, ranked #1248.

Federation des caisses Desjardins du Quebec first reported a position in AXSM in Q3 2021 and has held it in 3 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 2,764 shares of Axsome Therapeutics worth $677K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 441 Axsome Therapeutics shares in Q2 2026, an estimated $95.6K.
  • Axsome Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1248 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Axsome Therapeutics in Q3 2021 and has held it in 3 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.